Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
It was observed during the last period of COVID-19 pandemic that diabetic patients had a worse prognosis and more deteriorated clinical features than other patients
Diabetic patients infected with SAR-COV-19 were reported to have worse prognosis and faster deterioration in addition to higher rate for ICU admission when compared to other infected patients. In this study authors aim to investigate the certain cause for their case deterioration to be modified for better prognosis
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| control group | COVID-19 infected patients with no other comorbidities and they take the routine protocol from the Egyptian ministry of health |
| |
| diabetic group | COVID-19 infected patients with diabetes comorbidity and they receive the routine protocol for covid treatment in addition to their hypoglycemic drugs |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| no intervention as it is an observational study | Other | both groups will be monitored for the disease progress or deterioration and mortality rate |
|
| Measure | Description | Time Frame |
|---|---|---|
| Investigation of bad prognosis cause for covid-19 diabetic patients | number of diabetic patients with deteriorated case and to find the best hypoglycemic drug used for diabetic patients with covid-19 infection | 30 days |
Not provided
Not provided
Inclusion Criteria:
Patients infected with COVID-19 male or female 30 years old or more inpatients
Exclusion Criteria:
Not provided
Not provided
Not provided
Patients infected with COVID-19 either diabetic or have no comorbidities, inpatients
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Dalia Zaafar, PhD | Contact | +201117922833 | dr.moda88@gmail.com | |
| Amal Ahmed, PhD | Contact | +201224847367 | amalahmedhcp@yahoo.com |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Cairo University teaching hospitals | Recruiting | Cairo | Kasr Al Ainy | 11311 | Egypt |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D000086382 | COVID-19 |
| D003924 | Diabetes Mellitus, Type 2 |
| D003920 | Diabetes Mellitus |
| ID | Term |
|---|---|
| D011024 | Pneumonia, Viral |
| D011014 | Pneumonia |
| D012141 | Respiratory Tract Infections |
| D007239 | Infections |
Not provided
Not provided
Not provided
Not provided
Not provided
serum samoles for routine CBC, D dimer and INR tests
| D014777 |
| Virus Diseases |
| D018352 | Coronavirus Infections |
| D003333 | Coronaviridae Infections |
| D030341 | Nidovirales Infections |
| D012327 | RNA Virus Infections |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
| D004700 | Endocrine System Diseases |